• Issue

    The Prostate: Volume 79, Issue 16

    1791-1860
    December 1, 2019
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 1791
  • First Published: 01 November 2019

ORIGINAL ARTICLES

Overexpression of certain transient receptor potential and Orai channels in prostate cancer is associated with decreased risk of systemic recurrence after radical prostatectomy

M. A. Perrouin-Verbe MD, PhD,  N. Schoentgen MD,  M. Talagas MD, PhD,  R. Garlantezec MD, PhD,  A. Uguen MD, PhD,  L. Doucet MD,  S. Rosec,  P. Marcorelles MD, PhD,  M. Potier-Cartereau PhD,  C. Vandier PhD,  C. Ferec MD, PhD,  G. Fromont MD, PhD,  G. Fournier MD,  A. Valeri MD, PhD,  O. Mignen PhD, 
  • Pages: 1793-1804
  • First Published: 02 September 2019

The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer

Won Sik Jang MD,  Dong Hoon Koh MD,  Jongchan Kim MD,  Jong Soo Lee MD,  Doo Yong Chung MD,  Won Sik Ham MD, PhD,  Koon Ho Rha MD, PhD,  Young Deuk Choi MD, PhD, 
  • Pages: 1805-1810
  • First Published: 04 September 2019

Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer

Jordan E. Vellky BS,  Tyler M. Bauman MD,  Emily A. Ricke MS,  Wei Huang MD,  William A. Ricke PhD, 
  • Pages: 1811-1822
  • First Published: 10 September 2019

Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process

Zhenjie Zhu,  Yang Hong,  Fengshi Zhang,  Lizhe An MD,  Qingya Yang MD,  Xiaobo Huang MD,  Qingquan Xu MD, 
  • Pages: 1823-1831
  • First Published: 11 September 2019

Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancer

Felix Preisser MD,  Gilberto Coxilha,  Alexander Heinze,  Su Oh MD,  Felix K-H. Chun MD,  Guido Sauter MD,  Raisa S. Pompe MD,  Hartwig Huland MD,  Markus Graefen MD,  Derya Tilki MD, 
  • Pages: 1832-1836
  • First Published: 25 September 2019

Effective targeting of RNA polymerase I in treatment-resistant prostate cancer

Jin-Yih Low PhD,  Paul Sirajuddin PhD,  Michael Moubarek BS,  Shreya Agarwal BS,  Apurv Rege MS,  Gunes Guner MD,  Hester Liu MSc,  Zhiming Yang MD, PhD,  Angelo M. De Marzo MD, PhD,  Charles Bieberich PhD,  Marikki Laiho MD, PhD, 
  • Pages: 1837-1851
  • First Published: 16 September 2019
Open Access

Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer-specific mortality. A population-based study of 13 198 patients

Rune Kvåle MD, PhD,  Tor Å. Myklebust MSc, PhD,  Sophie D. Fosså MD,  Kirsti Aas MD,  Christian Ekanger MD,  Svein I. Helle MD, PhD,  Alfred Honoré MD,  Bjørn Møller MSc, PhD, 
  • Pages: 1852-1860
  • First Published: 30 September 2019